Dipiridamol (dipyridamole) coated tablets 0.025 №50

$8.00

Manufacturer: Ukraine

Purpose: Inhibits platelet aggregation, prevents blood clots in heart disease patients.

SKU: MED57888 Category:

Description

Dipiridamol (Dipyridamole) Coated Tablets 0.025 №50

Ingredients:

Each coated tablet contains 25 mg of Dipyridamole.

Dosage:

The usual dose is one tablet four times daily. It is important to follow the instructions provided by your healthcare provider.

Indications:

Dipiridamol tablets are indicated for the prevention of blood clots. They are often prescribed for individuals who have had heart valve replacement surgery.

Contraindications:

Do not take Dipiridamol if you are allergic to Dipyridamole or if you have a history of bleeding disorders. Consult your doctor for alternative options.

Directions:

Swallow the tablets whole with a glass of water. Do not crush or chew the tablets unless advised by your doctor.

Scientific Evidence:

Dipyridamole, the active ingredient in Dipiridamol tablets, works by inhibiting platelet aggregation and increasing cyclic adenosine monophosphate (cAMP) levels. This dual action helps to prevent the formation of blood clots. Studies have shown that Dipyridamole is effective in reducing the risk of thromboembolic events in patients with various cardiovascular conditions.

Additional Information:

It is important to inform your healthcare provider about all medications you are currently taking before starting Dipiridamol tablets. This includes prescription, over-the-counter, and herbal products. If you experience any unusual symptoms while taking this medication, seek medical attention immediately.

Pharmacological Effects:

Dipyridamole acts as a coronary vasodilator and inhibits adenosine uptake, leading to increased adenosine levels. This results in vasodilation and improved blood flow to the heart muscle. Additionally, Dipyridamole’s antiplatelet effects contribute to its role in preventing thrombus formation.

Clinical Trials and Comparative Effectiveness:

Clinical trials have demonstrated the efficacy of Dipyridamole in reducing the risk of recurrent stroke and other thromboembolic events. Compared to other antiplatelet agents, Dipyridamole has shown similar effectiveness in preventing clot formation while offering a favorable side effect profile.

Investigating the pharmacological properties and clinical outcomes of Dipiridamol (Dipyridamole) coated tablets 0.025 №50 can provide valuable insights into its therapeutic benefits and position in the management of cardiovascular conditions.